Share
Market Research Report

TOPICAL ANALGESIC MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassNon-Opioid Topical Analgesics (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Opioid-Based Topical Analgesics) · By Formulation (Creams, Gels, Sprays, Patches, Ointments & Balms, Others (Roll-Ons)) · By Therapeutic Application (Back Pain, Muscle Pain, Neck Pain, Osteoarthritis, Migraine, Headache and Cluster Headaches, Plantar Fasciitis, Sciatica, Bursitis, Chronic Myofascial Pain, Costochondritis, Frozen Shoulder , Gout, Acute, Radiculopathy, Spondylolisthesis, Temporomandibular Joint Disorder, Tendonitis, Toothache, Diabetic Peripheral Neuropathy, Rheumatoid Arthritis, Inflammatory Conditions, Others (Postoperative Pain, etc.)) · By Pain Type (Acute, Chronic) · By Distribution (Over-the-Counter (OTC), and Prescription-Based) · By Drug Type (Brand, and Generic) · By Drug Composition (Single, Combination) · By Gender (Male, Female) · By Age Group (Adult, Pediatric, and Geriatric) · By Distribution Channel (Hospitals Pharmacy, Retail Pharmacies, and Online Pharmacies) · By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa
  • Published In11 Mar 2026
  • Report CodeCMI8245
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  •  Drug Class Insights (Revenue, USD Bn, 2021 - 2033)

    • Non-Opioid Topical Analgesics
      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
        • Diclofenac
        • Ibuprofen
        • Ketoprofen
        • Piroxicam
      • Capsaicin-Based Analgesics
      • Methyl Salicylate (Salicylates)
      • Lidocaine and Local Anesthetics
      • CGRP Inhibitors
      • Other Non-Opioid Agents
    • Opioid-Based Topical Analgesics

  •  Formulation Insights (Revenue, USD Bn, 2021 - 2033)

    • Creams
    • Gels
    • Sprays
    • Patches
    • Ointments & Balms
    • Others (Roll-Ons)

  •  Therapeutic Application Insights (Revenue, USD Bn, 2021 - 2033)

    • Back Pain
    • Muscle Pain
    • Neck Pain
    • Osteoarthritis
    • Migraine
    • Headache and Cluster Headaches
    • Plantar Fasciitis
    • Sciatica
    • Bursitis
    • Chronic Myofascial Pain
    • Costochondritis
    • Gout, Acute
    • Radiculopathy
    • Spondylolisthesis
    • Temporomandibular Joint Disorder
    • Tendonitis
    • Toothache
    • Diabetic Peripheral Neuropathy
    • Rheumatoid Arthritis
    • Inflammatory Conditions
    • Others (Postoperative Pain, etc.)

  • Pain Type

    Insights (Revenue, USD Bn, 2021 - 2033)

    • Acute
    • Chronic

  • Distribution Insights (Revenue, USD Bn, 2021 - 2033)

    • Over-the-Counter (OTC)
    • Prescription-Based

  •  Drug Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Brand
    • Generic

  • Drug Composition Insights (Revenue, USD Bn, 2021 - 2033)

    • Single
    • Combination

  • Male Insights (Revenue, USD Bn, 2021 - 2033)

    • Male
    • Female

  • Age Group Insights (Revenue, USD Bn, 2021 - 2033)

    • Adult
    • Pediatric
    • Geriatric

  •  Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)

    • Hospitals Pharmacy
    • Retail Pharmacies
    • Online Pharmacies

  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa